At a Glance
Dosage
Only in DOI
oral
| Level | Dose |
|---|---|
| Threshold | 0.5 mg |
| Light | 0.5–1 mg |
| Common | 1–2 mg |
| Strong | 2–3 mg |
| Heavy | 3 mg |
Only in 25I-NBOMe
insufflated
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 200–500 µg |
| Common | 500–700 µg |
| Strong |
Duration
Only in DOI
oral
Onset
Come Up
Onset: 1 hrs – 2 hrsCome Up: 1.5 hrs – 3 hrs
Total: 16 hrs – 24 hrs
Only in 25I-NBOMe
insufflated
Afterglow
Onset: 5 min – 10 minCome Up: 10 min – 30 minPeak: 1 hrs – 2 hrs 2 hrs – 3 hrs
Effects
Safety
Interaction: DOI + 25I-NBOMe
No direct interaction data available between these substances. This does not mean the combination is safe.
DOI — Dangerous Interactions
No dangerous interactions recorded.
25I-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between DOI and 25I-NBOMe?
DOI is classified as a Psychedelic (Substituted amphetamines) while 25I-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 47 effects in common, with 6 effects unique to DOI and 11 unique to 25I-NBOMe.
Is it safe to combine DOI and 25I-NBOMe?
There is no direct interaction data available for combining DOI and 25I-NBOMe. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, DOI or 25I-NBOMe?
DOI and 25I-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.